Cargando…
Novel Anthracycline Utorubicin for Cancer Therapy
Novel anticancer compounds and their precision delivery systems are actively developed to create potent and well‐tolerated anticancer therapeutics. Here, we report the synthesis of a novel anthracycline, Utorubicin (UTO), and its preclinical development as an anticancer payload for nanocarriers. Fre...
Autores principales: | Simón‐Gracia, Lorena, Sidorenko, Valeria, Uustare, Ain, Ogibalov, Ivan, Tasa, Andrus, Tshubrik, Olga, Teesalu, Tambet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362190/ https://www.ncbi.nlm.nih.gov/pubmed/33908690 http://dx.doi.org/10.1002/anie.202016421 |
Ejemplares similares
-
Peritoneal Carcinomatosis Targeting with Tumor Homing Peptides
por: Simón-Gracia, Lorena, et al.
Publicado: (2018) -
Bi-Functional Peptides as a New Therapeutic Tool for Hepatocellular Carcinoma
por: Savier, Eric, et al.
Publicado: (2021) -
Targeting of Tomato Bushy Stunt Virus with a Genetically Fused C-End Rule Peptide
por: Marchetti, Luca, et al.
Publicado: (2023) -
Editorial on Special Issue “Precision Delivery of Drugs and Imaging Agents with Peptides”
por: Kurrikoff, Kaido, et al.
Publicado: (2022) -
Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics
por: Ewert, Kai K., et al.
Publicado: (2021)